This page is an illustration from Joerg Sigle's Programming Portfolio.

It shows the result file from a questionnaire administrtation with the original QL-Recorder.

Please note that, while maintaining downward compatibility, the modern QL-Recorder can provide much more information in its result files. Please visit www.ql-recorder.com for details.

Backlinks:     <relative: locally>     <absolute: via WWW>


SC-JMS Lebensqualit„ts-Recorder V 2.22 (C) 140296..191001 Dr. J”rg M. Sigle

[patient identification]

group/pid:     12A     
initials:      MM
date of birth: 01.02.1934

[time stamp]

date of test:  02.02.2009
start time:    16:10:56
end time:      16:12:10
delta time:    00:01:14 - valid only if start and end timed on the same day

[C30V2 = EORTC QLQ-C30 Version 2.0]

[C30V2 raw data]

C30V2 question nr. 1: N
C30V2 question nr. 2: J
C30V2 question nr. 3: N
C30V2 question nr. 4: N
C30V2 question nr. 5: J
C30V2 question nr. 6: 1
C30V2 question nr. 7: 2
C30V2 question nr. 8: 2
C30V2 question nr. 9: 1
C30V2 question nr. 10: 1
C30V2 question nr. 11: 1
C30V2 question nr. 12: 1
C30V2 question nr. 13: 2
C30V2 question nr. 14: 1
C30V2 question nr. 15: 1
C30V2 question nr. 16: 2
C30V2 question nr. 17: 1
C30V2 question nr. 18: 2
C30V2 question nr. 19: 2
C30V2 question nr. 20: 3
C30V2 question nr. 21: 4
C30V2 question nr. 22: 4
C30V2 question nr. 23: 1
C30V2 question nr. 24: 1
C30V2 question nr. 25: 1
C30V2 question nr. 26: 1
C30V2 question nr. 27: 1
C30V2 question nr. 28: 2
C30V2 question nr. 29: 5
C30V2 question nr. 30: 6

[C30V2 computed test results]

C30V2 physical function:                 60
C30V2 new role function:                 83
C30V2 emotional function:                50
C30V2 cognitive function:                67
C30V2 social function:                   100
C30V2 new global health/quality of life: 75
C30V2 fatigue:                           11
C30V2 nausea and vomiting:               0
C30V2 pain:                              17
C30V2 dyspnea:                           33
C30V2 sleep disturbance:                 0
C30V2 appetite loss:                     33
C30V2 constipation:                      33
C30V2 diarrhea:                          0
C30V2 financial impact:                  33

[end of file]